112 related articles for article (PubMed ID: 2645558)
1. [The role of bone scintigraphy and its value in the staging and follow up of prostatic carcinoma].
Adám E; Gervain M; Rajtár M; Oszlánczi J; Csernay L; Scultéty S
Orv Hetil; 1989 Feb; 130(7):335-40. PubMed ID: 2645558
[TBL] [Abstract][Full Text] [Related]
2. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
[TBL] [Abstract][Full Text] [Related]
3. [Cancer of the prostate: value of bone scintigraphy. Point of view].
Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
[TBL] [Abstract][Full Text] [Related]
4. [The usefulness of early whole body bone scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Furukawa Y; Tanaka H
Kaku Igaku; 1994 Jun; 31(6):541-50. PubMed ID: 7520953
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups.
Koizumi M; Motegi K; Koyama M; Terauchi T; Yuasa T; Yonese J
Ann Nucl Med; 2017 Aug; 31(7):521-528. PubMed ID: 28456877
[TBL] [Abstract][Full Text] [Related]
6. [The clinical value of bone scintigraphy in the diagnosis of prostatic neoplasm metastases].
Sintermann R; Langhammer H
Med Welt; 1979 Jun; 30(24):929-312. PubMed ID: 459815
[No Abstract] [Full Text] [Related]
7. Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer.
Langhammer H; Sintermann R; Hör G; Pabst HW
Nuklearmedizin; 1978 Jul; 17(3):87-91. PubMed ID: 568257
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic evaluation of the skeleton in multiple myeloma.
Wahner HW; Kyle RA; Beabout JW
Mayo Clin Proc; 1980 Dec; 55(12):739-46. PubMed ID: 7218877
[TBL] [Abstract][Full Text] [Related]
9. [Is bone scan useful in patients with breast cancer localized on the basis of clinical examination. 143 cases (author's transl)].
Stines J; Stalars J; Dartois D; Chardot C
Bull Cancer; 1980; 67(3):319-23. PubMed ID: 7407430
[TBL] [Abstract][Full Text] [Related]
10. The "super" bone scan.
Higginbotham EA
J Natl Med Assoc; 1980 Mar; 72(3):291-4. PubMed ID: 7392072
[No Abstract] [Full Text] [Related]
11. [Bone metastases of prostatic neoplasms with reference to the histological type and local tumor stage].
Langerhammer H; Steuer G; Gradinger R; Sintermann R; Pabst HW
Schweiz Med Wochenschr; 1980 Jan; 110(1):11-5. PubMed ID: 6244617
[TBL] [Abstract][Full Text] [Related]
12. [Studies on prognosis of prostate cancer with bone metastasis by using pretreatment bone scintigraphy].
Kubota Y; Numasawa K; Suzuki H; Kakizaki H; Suzuki K
Hinyokika Kiyo; 1989 Oct; 35(10):1693-9. PubMed ID: 2610178
[TBL] [Abstract][Full Text] [Related]
13. Serial bone scanning in the evaluation of stage and clinical course in carcinoma of the prostate.
Johansson JE; Beckman KW; Lindell D; Lingårdh ; Rydman H; Vikterlöf KJ
Scand J Urol Nephrol Suppl; 1980; 55():31-6. PubMed ID: 6938033
[TBL] [Abstract][Full Text] [Related]
14. The staging of M1 disease: the role of bone scan, Xray and other imaging techniques.
Richards B; Bollack C; Bouffioux C
Prog Clin Biol Res; 1988; 269():233-42. PubMed ID: 3293062
[TBL] [Abstract][Full Text] [Related]
15. Skeletal scintigraphy for routine surveillance of M0 prostatic carcinoma.
Carter SS; Hilson AJ; Constable AR; Lewis CA; Shah PJ; O'Donoghue EP
Contrib Nephrol; 1987; 56():267-72. PubMed ID: 3608500
[No Abstract] [Full Text] [Related]
16. Efficacy of follow-up bone scans in carcinoma of the prostate.
Corrie D; Timmons JH; Bauman JM; Thompson IM
Cancer; 1988 Jun; 61(12):2453-4. PubMed ID: 3130180
[TBL] [Abstract][Full Text] [Related]
17. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
Goodman CM; Cumming JA; Ritchie AW; Chisholm GD
Br J Urol; 1991 Jun; 67(6):622-5. PubMed ID: 2070208
[TBL] [Abstract][Full Text] [Related]
19. [Value of urinary time in bone scintigraphy in the evaluation of renal function. Apropos of 57 cases of cancer of the prostate].
Amiel J; Quintens H; Lapalus F; Raymond G; Toubol J
J Urol (Paris); 1987; 93(8):467-8. PubMed ID: 3440839
[TBL] [Abstract][Full Text] [Related]
20. [Staging in prostate carcinoma].
Trinkler FB; Böni RA; Krestin GP
Ther Umsch; 1995 Jun; 52(6):399-404. PubMed ID: 7604393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
